“Passive” Botanicals Surveillance Should Mimic Drug AER System – ER Doc
This article was originally published in The Tan Sheet
Plant-derived supplements should be monitored under an active surveillance system similar to drugs, according to botanist and emergency-room physician Mary Palmer, MD, George Washington Medical Center
You may also be interested in...
The American Society for Clinical Pharmacology & Therapeutics is calling for legislation and funding that would enable FDA to improve the detection and assessment of adverse events associated with dietary supplement use
FDA issued a public advisory Sept. 10 warning against consumption of teas brewed from the herb star anise, based on reports such products have been associated with health problems affecting 40 individuals, including approximately 15 infants
Almost 14% of dietary supplement adverse events reported to poison control centers included in an analysis involved children under age 12, according to a study published in the Jan. 11 issue of The Lancet